NEW EMERGING TECHNOLOGIES
Emerging Product Technologies
Exploring new ways to formulate, deliver and use healthcare productsAlongside its therapeutic focus on women’s health and dermatology, Contrad evaluates emerging technologies that can enable differentiated healthcare products. The interest is not limited to a specific indication; it centres on technologies that improve how an active ingredient is delivered, how a product performs or how easily it can be used in everyday practice.
Areas of interest include:
- Advanced topical, transdermal, mucosal and vaginal delivery systems
- Technologies improving bioavailability, stability or targeted delivery
- Controlled- and sustained-release formulations
- Innovative non-hormonal platforms
- Drug–device combinations and novel application formats
- Patient-friendly products supporting self-administration, adherence and longer-term use
- Technologies with potential applications across several conditions or product categories
Contrad is particularly interested in technologies that have progressed beyond the conceptual stage and are supported by credible scientific evidence. Their intellectual-property position, regulatory pathway, manufacturing feasibility and ability to create clinically meaningful differentiation must be sufficiently clear to support further development and commercialization.
